Follow the people · Insider
Jeffrey G. Black
Jeffrey G. Black files insider transactions with the SEC as a chief financial officer of Exagen (XGN). We hold 2 disclosed purchases and sales filed since 22 December 2008, 1 of them in the last 90 days.
- Files forXGN
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure2 September 2026
Positions held
5 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 September 2024 — 1 September 2026Chief Financial Officer · Exagen (XGN)15 Form 4 lines · source: SEC Form 4
- Filed 15 May 2023 — 20 August 2024SVP & Chief Financial Officer · Standard Biotools (LAB)13 Form 4 lines · source: SEC Form 4
- Filed 9 August 2021 — 4 April 2023Chief Financial Officer · Apollo Endosurgery (APEN)14 Form 4 lines · source: SEC Form 4
- Filed 6 March 2017 — 9 March 2021EVP & CFO · Alphatec Holdings (ATEC)26 Form 4 lines · source: SEC Form 4
- Filed 20 December 2008 — 31 October 2013Sr. Vice President & CFO · Verenium (VRNM)36 Form 4 lines · source: SEC Form 4
Everything they disclosed
104 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 20,614 shares of ExagenSEC Form 42 September 2026Common Stock · traded 1 September 2026 · filed 2 September 2026
- was granted 1,571 shares of ExagenSEC Form 42 September 2026Common Stock · traded 1 September 2026 · filed 2 September 2026
- was granted 75,000 shares of ExagenSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- was granted 1,511 shares of ExagenSEC Form 416 March 2026Common Stock · traded 27 February 2026 · filed 16 March 2026
- was granted 50,000 shares of Exagen (a derivative holding)SEC Form 416 March 2026Stock Option(right to buy) · traded 12 March 2026 · filed 16 March 2026
- was granted 50,000 shares of Exagen (a derivative holding)SEC Form 416 March 2026Stock Option(right to buy) · traded 12 March 2026 · filed 16 March 2026
- was granted 75,000 shares of ExagenSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- was granted 1,511 shares of ExagenSEC Form 416 March 2026Common Stock · traded 27 February 2026 · filed 16 March 2026
- ▼ sold on the open market 1,584 shares of ExagenSEC Form 425 February 2026Common Stock · traded 24 February 2026 · filed 25 February 2026
- ▼ sold on the open market 1,584 shares of ExagenSEC Form 425 February 2026Common Stock · traded 24 February 2026 · filed 25 February 2026
- ▼ sold on the open market 20,466 shares of ExagenSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- was granted 10,000 shares of Exagen (a derivative holding)SEC Form 425 February 2025Stock Option(right to buy) · traded 21 February 2025 · filed 25 February 2025
- was granted 15,000 shares of ExagenSEC Form 425 February 2025Common Stock · traded 21 February 2025 · filed 25 February 2025
- ▲ bought on the open market 22,298 shares of ExagenSEC Form 419 November 2024Common Stock · traded 15 November 2024 · filed 19 November 2024
- had shares withheld for tax on 6,690 shares of Standard BiotoolsSEC Form 45 September 2024Common Stock · traded 20 August 2024 · filed 5 September 2024
- was granted 225,000 shares of ExagenSEC Form 44 September 2024Common Stock · traded 1 September 2024 · filed 4 September 2024
- exercised options over 13,157 shares of Standard Biotools (a derivative holding)SEC Form 419 August 2024Restricted Stock Units · traded 15 August 2024 · filed 19 August 2024
- exercised options over 13,157 shares of Standard BiotoolsSEC Form 419 August 2024Common Stock · traded 15 August 2024 · filed 19 August 2024
- had shares withheld for tax on 4,695 shares of Standard BiotoolsSEC Form 419 August 2024Common Stock · traded 15 August 2024 · filed 19 August 2024
- was granted 400,000 shares of Standard Biotools (a derivative holding)SEC Form 421 May 2024Stock Option (Right to Buy) · traded 20 May 2024 · filed 21 May 2024
- was granted 300,000 shares of Standard BiotoolsSEC Form 421 May 2024Common Stock · traded 20 May 2024 · filed 21 May 2024
- exercised options over 52,631 shares of Standard Biotools (a derivative holding)SEC Form 416 May 2024Common Stock · traded 15 May 2024 · filed 16 May 2024
- exercised options over 52,631 shares of Standard BiotoolsSEC Form 416 May 2024Common Stock · traded 15 May 2024 · filed 16 May 2024
- had shares withheld for tax on 18,779 shares of Standard BiotoolsSEC Form 416 May 2024Common Stock · traded 15 May 2024 · filed 16 May 2024
- ▲ bought on the open market 43,492 shares of Standard BiotoolsSEC Form 422 May 2023Common Stock · traded 18 May 2023 · filed 22 May 2023
- ▲ bought on the open market 42,492 shares of Standard BiotoolsSEC Form 422 May 2023Common Stock · traded 19 May 2023 · filed 22 May 2023
- was granted 210,526 shares of Standard Biotools (a derivative holding)SEC Form 417 May 2023Restricted Stock Units · traded 15 May 2023 · filed 17 May 2023
- was granted 400,000 shares of Standard Biotools (a derivative holding)SEC Form 417 May 2023Stock Option (Right to Buy) · traded 15 May 2023 · filed 17 May 2023
- returned to the issuer 150,000 shares of Apollo Endosurgery (a derivative holding)SEC Form 44 April 2023Stock Option (Right to Buy) · traded 4 April 2023 · filed 4 April 2023
- returned to the issuer 120,834 shares of Apollo Endosurgery (a derivative holding)SEC Form 44 April 2023Stock Option (Right to Buy) · traded 4 April 2023 · filed 4 April 2023
- returned to the issuer 335,330 shares of Apollo EndosurgerySEC Form 44 April 2023Common Stock · traded 4 April 2023 · filed 4 April 2023
- had shares withheld for tax on 15,060 shares of Apollo EndosurgerySEC Form 44 November 2022Common Stock · traded 4 November 2022 · filed 4 November 2022
- had shares withheld for tax on 6,190 shares of Apollo EndosurgerySEC Form 45 August 2022Common Stock · traded 5 August 2022 · filed 5 August 2022
- was granted 120,834 shares of Apollo Endosurgery (a derivative holding)SEC Form 416 June 2022Stock Option (Right to Buy) · traded 14 June 2022 · filed 16 June 2022
- was granted 88,900 shares of Apollo EndosurgerySEC Form 416 June 2022Common Stock · traded 14 June 2022 · filed 16 June 2022
- ▲ bought on the open market 15,000 shares of Apollo EndosurgerySEC Form 41 March 2022Common Stock · traded 25 February 2022 · filed 1 March 2022
- ▲ bought on the open market 15,000 shares of Apollo EndosurgerySEC Form 41 March 2022Common Stock · traded 28 February 2022 · filed 1 March 2022
- ▲ bought on the open market 10,000 shares of Apollo EndosurgerySEC Form 41 March 2022Common Stock · traded 1 March 2022 · filed 1 March 2022
- ▲ bought on the open market 25,000 shares of Apollo EndosurgerySEC Form 411 August 2021Common Stock · traded 11 August 2021 · filed 11 August 2021
- was granted 120,000 shares of Apollo EndosurgerySEC Form 411 August 2021Common Stock · traded 9 August 2021 · filed 11 August 2021
- was granted 80,000 shares of Apollo EndosurgerySEC Form 411 August 2021Common Stock · traded 9 August 2021 · filed 11 August 2021
- was granted 150,000 shares of Apollo Endosurgery (a derivative holding)SEC Form 411 August 2021Stock Option (Right to Buy) · traded 9 August 2021 · filed 11 August 2021
- ▼ sold on the open market 7,000 shares of Alphatec HoldingsSEC Form 410 March 2021Common Stock · traded 9 March 2021 · filed 10 March 2021
- ▼ sold on the open market 25,000 shares of Alphatec HoldingsSEC Form 418 February 2021Common Stock · traded 16 February 2021 · filed 18 February 2021
- ▼ sold on the open market 5,000 shares of Alphatec HoldingsSEC Form 413 August 2020Common Stock · traded 11 August 2020 · filed 13 August 2020
- ▼ sold on the open market 8,929 shares of Alphatec HoldingsSEC Form 46 August 2020Common Stock · traded 4 August 2020 · filed 6 August 2020
- had shares withheld for tax on 23,774 shares of Alphatec HoldingsSEC Form 415 May 2020Common Stock · traded 14 May 2020 · filed 15 May 2020
- was granted 179,178 shares of Alphatec HoldingsSEC Form 424 April 2020Common Stock · traded 22 April 2020 · filed 24 April 2020
- was granted 5,996 shares of Alphatec HoldingsSEC Form 48 April 2020Common Stock · traded 6 April 2020 · filed 8 April 2020
- ▼ sold on the open market 6,563 shares of Alphatec HoldingsSEC Form 412 March 2020Common Stock · traded 10 March 2020 · filed 12 March 2020
- ▼ sold on the open market 8,929 shares of Alphatec HoldingsSEC Form 42 August 2019Common Stock · traded 2 August 2019 · filed 2 August 2019
- was granted 275,000 shares of Alphatec HoldingsSEC Form 415 May 2019Common Stock · traded 13 May 2019 · filed 15 May 2019
- was granted 68,750 shares of Alphatec HoldingsSEC Form 415 May 2019Common Stock · traded 13 May 2019 · filed 15 May 2019
- was granted 102,041 shares of Alphatec HoldingsSEC Form 41 August 2018Common Stock · traded 30 July 2018 · filed 1 August 2018
- was granted 148,445 shares of Alphatec Holdings (a derivative holding)SEC Form 41 August 2018Employee Stock Option (right to buy) · traded 30 July 2018 · filed 1 August 2018
- exercised options over 15,874 shares of Alphatec HoldingsSEC Form 421 May 2018Common Stock · traded 17 May 2018 · filed 21 May 2018
- exercised options over 50 shares of Alphatec Holdings (a derivative holding)SEC Form 421 May 2018Series B Convertible Preferred Stock · traded 17 May 2018 · filed 21 May 2018
- was granted 50 shares of Alphatec Holdings (a derivative holding)SEC Form 412 March 2018Series B Convertible Preferred Stock · traded 8 March 2018 · filed 12 March 2018
- was granted 13,492 shares of Alphatec Holdings (a derivative holding)SEC Form 412 March 2018Warrants (right to buy) · traded 8 March 2018 · filed 12 March 2018
- ▲ bought on the open market 5,000 shares of Alphatec HoldingsSEC Form 417 August 2017Common Stock · traded 17 August 2017 · filed 17 August 2017
- ▲ bought on the open market 4,000 shares of Alphatec HoldingsSEC Form 416 August 2017Common Stock · traded 16 August 2017 · filed 16 August 2017
- was granted 193,000 shares of Alphatec Holdings (a derivative holding)SEC Form 427 July 2017Employee Stock Option (right to buy) · traded 26 July 2017 · filed 27 July 2017
- exercised options over 25,000 shares of Alphatec HoldingsSEC Form 414 July 2017Common Stock · traded 14 July 2017 · filed 14 July 2017
- exercised options over 50 shares of Alphatec Holdings (a derivative holding)SEC Form 414 July 2017Series A Convertible Preferred Stock · traded 14 July 2017 · filed 14 July 2017
- was granted 75,000 shares of Alphatec HoldingsSEC Form 431 March 2017Common Stock - Restricted Stock Units · traded 31 March 2017 · filed 31 March 2017
- was granted 50 shares of Alphatec Holdings (a derivative holding)SEC Form 431 March 2017Series A Convertible Preferred Stock · traded 29 March 2017 · filed 31 March 2017
- was granted 25,000 shares of Alphatec Holdings (a derivative holding)SEC Form 431 March 2017Warrants (right to buy) · traded 29 March 2017 · filed 31 March 2017
- was granted 75,000 shares of Alphatec Holdings (a derivative holding)SEC Form 415 March 2017Stock Option (Right to Buy) · traded 6 March 2017 · filed 15 March 2017
- returned to the issuer 25,000 shares of Verenium (a derivative holding)SEC Form 44 November 2013Employee Stock Option (Right to Buy) · traded 31 October 2013 · filed 4 November 2013
- returned to the issuer 42,626 shares of Verenium (a derivative holding)SEC Form 44 November 2013Employee Stock Option (Right to Buy) · traded 31 October 2013 · filed 4 November 2013
- returned to the issuer 10,000 shares of Verenium (a derivative holding)SEC Form 44 November 2013Employee Stock Option (Right to Buy) · traded 31 October 2013 · filed 4 November 2013
- returned to the issuer 24,412 shares of Verenium (a derivative holding)SEC Form 44 November 2013Employee Stock Option (Right to Buy) · traded 31 October 2013 · filed 4 November 2013
- returned to the issuer 31,400 shares of Verenium (a derivative holding)SEC Form 44 November 2013Incentive Stock Option (Right to Buy) · traded 31 October 2013 · filed 4 November 2013
- returned to the issuer 15,974 shares of Verenium (a derivative holding)SEC Form 44 November 2013Non-Qualified Stock Option (Right to Buy) · traded 31 October 2013 · filed 4 November 2013
- returned to the issuer 588 shares of Verenium (a derivative holding)SEC Form 44 November 2013Non-Qualified Stock Option (Right to Buy) · traded 31 October 2013 · filed 4 November 2013
- returned to the issuer 4,375 shares of VereniumSEC Form 44 November 2013Common Stock · traded 31 October 2013 · filed 4 November 2013
- returned to the issuer 1,750 shares of VereniumSEC Form 44 November 2013Common Stock · traded 31 October 2013 · filed 4 November 2013
- was granted 25,000 shares of Verenium (a derivative holding)SEC Form 42 August 2013Employee Stock Option (Right to Buy) · traded 1 August 2013 · filed 2 August 2013
- was granted 24,412 shares of Verenium (a derivative holding)SEC Form 43 August 2012Employee Stock Option (Right to Buy) · traded 2 August 2012 · filed 3 August 2012
- was granted 588 shares of Verenium (a derivative holding)SEC Form 43 August 2012Non-Qualified Stock Option (Right to Buy) · traded 2 August 2012 · filed 3 August 2012
- ▲ bought on the open market 125 shares of VereniumSEC Form 416 August 2011Common Stock · traded 15 August 2011 · filed 16 August 2011
- ▲ bought on the open market 200 shares of VereniumSEC Form 416 August 2011Common Stock · traded 15 August 2011 · filed 16 August 2011
- ▲ bought on the open market 450 shares of VereniumSEC Form 416 August 2011Common Stock · traded 15 August 2011 · filed 16 August 2011
- ▲ bought on the open market 1,100 shares of VereniumSEC Form 416 August 2011Common Stock · traded 16 August 2011 · filed 16 August 2011
- was granted 42,626 shares of Verenium (a derivative holding)SEC Form 41 March 2011Employee Stock Option (Right to Buy) · traded 24 February 2011 · filed 1 March 2011
- was granted 31,400 shares of Verenium (a derivative holding)SEC Form 49 September 2010Incentive Stock Option (Right to Buy) · traded 7 September 2010 · filed 9 September 2010
- ▲ bought on the open market 1,500 shares of VereniumSEC Form 418 August 2010Common Stock · traded 16 August 2010 · filed 18 August 2010
- ▲ bought on the open market 2,750 shares of VereniumSEC Form 418 August 2010Common Stock · traded 17 August 2010 · filed 18 August 2010
- was granted 1,809 shares of Verenium (a derivative holding)SEC Form 419 May 2010Non-Qualified Stock Option (Right to Buy) · traded 12 November 2009 · filed 19 May 2010
- was granted 5,646 shares of Verenium (a derivative holding)SEC Form 419 May 2010Non-Qualified Stock Option (Right to Buy) · traded 12 November 2009 · filed 19 May 2010
- was granted 2,687 shares of Verenium (a derivative holding)SEC Form 419 May 2010Non-Qualified Stock Option (Right to Buy) · traded 12 November 2009 · filed 19 May 2010
- was granted 5,103 shares of Verenium (a derivative holding)SEC Form 419 May 2010Non-Qualified Stock Option (Right to Buy) · traded 12 November 2009 · filed 19 May 2010
- was granted 729 shares of Verenium (a derivative holding)SEC Form 419 May 2010Non-Qualified Stock Option (Right to Buy) · traded 12 November 2009 · filed 19 May 2010
- was granted 10,000 shares of Verenium (a derivative holding)SEC Form 415 December 2009Employee Stock Option (Right to Buy) · traded 11 December 2009 · filed 15 December 2009
- returned to the issuer 2,713 shares of Verenium (a derivative holding)SEC Form 416 November 2009Employee Stock Option (Right to Buy) · traded 12 November 2009 · filed 16 November 2009
- returned to the issuer 4,030 shares of Verenium (a derivative holding)SEC Form 416 November 2009Employee Stock Option (Right to Buy) · traded 12 November 2009 · filed 16 November 2009
- returned to the issuer 8,469 shares of Verenium (a derivative holding)SEC Form 416 November 2009Employee Stock Option (Right to Buy) · traded 12 November 2009 · filed 16 November 2009
- returned to the issuer 729 shares of Verenium (a derivative holding)SEC Form 416 November 2009Employee Stock Option (Right to Buy) · traded 12 November 2009 · filed 16 November 2009
- returned to the issuer 5,103 shares of Verenium (a derivative holding)SEC Form 416 November 2009Employee Stock Option (Right to Buy) · traded 12 November 2009 · filed 16 November 2009
- was granted 1,809 shares of Verenium (a derivative holding)SEC Form 416 November 2009Employee Stock Option (Right to Buy) · traded 12 November 2009 · filed 16 November 2009
- was granted 4,656 shares of Verenium (a derivative holding)SEC Form 416 November 2009Employee Stock Option (Right to Buy) · traded 12 November 2009 · filed 16 November 2009
- was granted 2,687 shares of Verenium (a derivative holding)SEC Form 416 November 2009Employee Stock Option (Right to Buy) · traded 12 November 2009 · filed 16 November 2009
- was granted 5,832 shares of Verenium (a derivative holding)SEC Form 416 November 2009Employee Stock Option (Right to Buy) · traded 12 November 2009 · filed 16 November 2009
- returned to the issuer 1,667 shares of VereniumSEC Form 422 December 2008Common Stock · traded 20 December 2008 · filed 22 December 2008
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.